Academic Journal
Quartile not availableThe Cerebellum
About The Cerebellum
About The Cerebellum
The Cerebellum is an international, peer-reviewed neuroscience journal published by Springer, as part of Springer Science+Business Media, under journal code 12311. Its print ISSN is 1473-4222 and its electronic ISSN is 1473-4230. Bibliographic listings date the start of publication to 2002, and the title has been published continuously since that year, building a specialist archive that is devoted to a single brain structure rather than to neuroscience in general. That narrow, deliberate focus is the defining feature of the journal, and it shapes every question an author, reader, librarian or evaluator should ask about it.
Springer describes the journal, in its own aims and scope statement, as an international journal devoted to the science of the cerebellum and its role in ataxia and other medical disorders. The publisher notes that there is currently intense interest in the genetics of cerebellar ataxias and in the roles of the cerebellum in motor control and cognitive functioning, and it observes that this region of the brain contains more neurons than all the other structures of the brain combined. As the population ages, Springer adds, diseases associated with cerebellar dysfunction are becoming more widespread, which increases the clinical as well as the scientific importance of a dedicated venue.
Before this journal existed, researchers working on the cerebellum had to publish in, and search across, a wide range of general neuroscience, neurology, anatomy and physiology publications. The founding idea, as Springer presents it, was therefore consolidation: to cover all the latest developments in the field from one source, supported by an editorial board of internationally recognised experts, so that readers could keep fully up to date without assembling the literature from scattered places. Understanding that founding purpose helps a prospective author judge fit. A manuscript belongs here when the cerebellum itself, a cerebellar circuit, a cerebellar disorder or a cerebellar mechanism is the centre of the work, not a background detail.
The founding editor is Mario Manto, a neurologist at the Université Libre de Bruxelles in Belgium, a professor of neuroanatomy at the University of Mons and a researcher with the Fonds National de la Recherche Scientifique. Biographical sources record that Manto, whose career has focused for more than twenty years on cerebellar disorders from both a clinical and a basic science point of view, is the founding editor and editor-in-chief of The Cerebellum and also founded its sister title devoted to cerebellar ataxias. He has published extensively on cerebellar topics, edited multiple books on cerebellar disorders, and led work on clinical neurology at the Centre Hospitalier Universitaire de Charleroi. That editorial lineage matters because the journal was created by a clinician-scientist inside the field it serves, rather than as a general medical title that later added a cerebellar section.
Scope: What the Journal Publishes
The scope can be understood through five connected areas. Each area is a genuine route into the journal, and the strongest submissions usually make clear, in the title, abstract and introduction, which area they address and why the cerebellar angle is new.
1. Cerebellar ataxias and cerebellar disorders
Genetics, diagnosis and clinical characterisation of the cerebellar ataxias sit at the centre of the journal. Work on hereditary ataxias, including the spinocerebellar ataxias, on acquired and idiopathic forms, and on the classification and natural history of cerebellar syndromes speaks directly to the readership. The consensus literature published in the journal illustrates the level expected: a widely cited consensus paper on the role of the cerebellum in movement and cognition, and a consensus paper on the roles of the cerebellum in motor control, both gathered leading specialists to settle terminology, mechanisms and research priorities for the whole field.
2. Motor control, circuits and neurophysiology
A second core area is how cerebellar circuits produce coordinated movement and motor learning. Studies of the cerebellar cortex, granule cells, inhibitory transmission, synaptic mechanisms, connectivity and neural circuit dynamics are in scope when they explain function rather than merely describe anatomy. Laboratory work using electrophysiology, stimulation methods such as transcranial magnetic stimulation, and computational modelling has a natural home here, provided the authors connect the mechanism to cerebellar operation in a way that a broad cerebellar audience can follow.
3. Cognition, emotion and neuropsychiatry
Modern cerebellar science no longer treats the structure as a purely motor device, and neither does this journal. Research on the contribution of the cerebellum to cognition, working memory, language, executive function, emotion and social behaviour is a recognised part of the scope. A highly cited article on the neuropsychiatry of the cerebellum shows the standing of this line of work. Authors in this area should be especially careful to specify the cerebellar territory, pathway or patient population involved, because claims about cognition are strongest when they are anatomically and clinically precise.
4. Development, anatomy, imaging and biomarkers
Work on cerebellar development, malformations of the posterior fossa, structural and functional imaging, and candidate biomarkers for cerebellar disease also fits the journal. Imaging studies are expected to do more than present pictures: they should test a hypothesis about structure, function, diagnosis, prognosis or treatment response. Developmental work should likewise make its relevance to later cerebellar function or disorder explicit.
5. Treatment, rehabilitation and clinical management
Pharmacological approaches, neuromodulation, rehabilitation strategies and other interventions aimed at improving motor or cognitive function in cerebellar disease complete the scope. Clinical reports are most competitive when they change understanding or practice: a new genotype-phenotype correlation, a carefully documented treatment response, or a case that forces a diagnostic distinction, carries more weight than a routine presentation of a well-known condition.
Article Types and How to Choose
The journal publishes original research, reviews and clinical material, and its archive includes consensus papers that organise an entire subfield. Choosing the right article type is a practical decision, not a formality, because reviewers judge each type against a different standard.
- Original research should report a defined question, a reproducible method, results that answer the question, and a discussion that places the cerebellar contribution in context.
- Review articles should synthesise, compare and evaluate the literature, identify disagreements, and state what evidence would resolve them; a simple summary of papers in chronological order rarely meets that standard.
- Consensus and guideline-type papers carry authority only when they genuinely represent expert agreement reached through a transparent process.
- Case-based and clinical reports should foreground the lesson that generalises beyond the single patient.
- Shorter contributions should still be complete pieces of scholarship, with a clear claim and the evidence needed to support it.
Authors should check the current Springer submission guidelines for the precise list of article categories, word limits, figure requirements and reference style in force at the time of submission, because publishers revise those operational details. The scientific standard, however, is stable: novelty located specifically in cerebellar science, methods strong enough to support the claim, and writing that allows specialists from neighbouring areas — genetics, neurology, physiology, radiology, paediatrics, neuropsychology — to understand why the result matters.
Editorial Process, Peer Review and Ethics
The Cerebellum operates as a conventional peer-reviewed Springer journal. Manuscripts are submitted through the publisher's online system, are first assessed for scope and basic quality, and are then sent to expert reviewers when they pass that initial assessment. Authors should expect reviewers who know the cerebellar literature in detail. Vague claims about novelty are therefore risky: a reviewer in this field will know the prior consensus papers, the established animal models and the standard clinical classifications, and will test a submission against them.
Ethical requirements follow standard Springer and international practice. Human research needs appropriate ethics approval and informed consent, with identifying details protected. Animal research needs an approved protocol and a clear statement of welfare safeguards. Clinical images, genetic information and case material require particular care, because cerebellar disorders are often rare and a combination of age, place, mutation and clinical detail can identify a patient even when a name is removed. Conflicts of interest, funding sources and author contributions should be disclosed fully at submission, not added after questions are raised.
Data and materials transparency strengthens a submission in this field. Imaging parameters, stimulation settings, genetic variant nomenclature, primer or model details, and statistical methods should be reported completely enough for another laboratory to repeat the work. Where a study uses a named scale for ataxia or a standard neuropsychological battery, the version, language and scoring should be stated. These are not bureaucratic extras; in a small, cumulative field, comparability between papers is how progress is measured.
Indexing, Metrics and How to Read Them
Secondary bibliographic listings record The Cerebellum as indexed in Scopus, in the Science Citation Index Expanded within Web of Science, in PubMed and in Embase. Authors who need indexing for a promotion, thesis or funder requirement should verify the current status directly in the relevant database on the date they rely on it, because database coverage can change and a directory entry in this profile is a guide, not a guarantee. The journal's long coverage, recorded from 2002 in Scopus-based listings, is itself a useful stability signal.
Reported metrics should be quoted with their source and year. Researcher.Life, drawing on Scopus data, lists a CiteScore of 5.9 and an h-index of 90 for the title, with a Source Normalized Impact per Paper value of 1.25. Journal-search listings updated in June 2025 report a Journal Impact Factor of 2.4 and a SCImago Journal Rank of about 1.016, placing the title in the first quartile for Medicine (miscellaneous) and the second quartile for Neurology and for Clinical Neurology in that listing. The JournalsWorld record for the related Cerebellum entry reports an h-index of 94, which illustrates why a single number should never be repeated without its source: different providers count documents and citations over different windows and arrive at different, individually defensible figures.
The correct way to use these numbers is comparative and contextual. A specialist journal that serves one brain structure will never accumulate the citation volume of a general medical weekly, and it should not be judged as if it should. What matters for an author is whether the right specialists read and cite the journal, whether its papers appear in the databases an institution counts, and whether recent articles in the author's exact topic have been noticed. Reading the citation history of the five closest papers already published in the journal tells an author more about likely visibility than any headline metric.
- Check the Journal Impact Factor only in Journal Citation Reports if your institution requires that exact measure.
- Check Scopus coverage in the Scopus source list, not in a third-party summary.
- Compare quartiles within the same category and year; a quartile without a category is meaningless.
- Look at recent volumes to confirm the journal is actively publishing in your topic now, not only historically.
Audience and Community
Springer names the intended readership explicitly: neuroscientists in molecular and cellular biology, neurophysiologists, researchers in neurotransmission, neurologists, geneticists, radiologists, paediatricians, anatomists and neuropsychologists, together with trainees in neurology and psychiatry. That list explains the writing task. A submission must be technically exact for its own specialists and still intelligible to the neighbouring disciplines on that list. Define abbreviations, explain specialist techniques briefly, and state the clinical or biological implication in plain language at least once in the abstract and once in the discussion.
The community around the journal overlaps with the community around cerebellar ataxia research and care. The closure notice for the sister open-access title Cerebellum and Ataxias, which ceased publication with its publisher after 31 December 2021, directed authors to consider The Cerebellum instead, which confirms the position of this title as the continuing Springer home for the field. For authors choosing between a general neurology journal and this specialist title, the trade-off is reach against concentration: a general title may be seen by more people, while this journal is read closely by the people most likely to use, cite and build on cerebellar work.
Preparing and Submitting a Manuscript
Start with a fit check that can be done in an afternoon. Search the journal's recent volumes for your exact topic, your method and your disorder or model. If the journal has published similar work, read how those papers framed their contribution and cite the relevant ones honestly. If the journal has published nothing similar for many years, consider whether the cerebellar connection in your work is central enough, or whether a different venue would serve the paper better. Editors welcome a confident, specific case for fit; they are rarely persuaded by a claim that a paper is important in general.
Structure the manuscript so the cerebellar claim is easy to test. The introduction should move from the general problem to the specific cerebellar gap in a few paragraphs. The methods should name the population, model, intervention or dataset with precision. Results should be presented in the order the questions were asked. The discussion should separate what the data show from what the authors infer, acknowledge the limits of a single cohort, model or imaging sample, and end with the concrete next question the work opens. Figures that show anatomy, circuits, timelines or individual patient trajectories are often more informative in this field than dense tables, but every figure must earn its space.
Before submitting, complete the mechanical checks that most often delay a Springer manuscript: a title that names the cerebellar topic, an abstract that states design, sample, main result and conclusion, keywords that match the vocabulary of the field, references formatted to the current journal style, figure files at the required resolution, ethics and consent statements in place, and all author names, affiliations and contact details verified. Confirm the article processing position for your chosen publication route directly on the Springer page for the journal, because open-access charges and licence options are publisher-set details that change over time and are not publicly disclosed in the secondary listings used for this profile in a form that should be copied forward.
Rejection, when it comes, is usually informative in a specialist journal. A decision that a paper is out of scope is a signal to retarget, not to resubmit unchanged. A decision after review that identifies a missing control, an underpowered sample or an unsupported cognitive claim points to work that would strengthen the paper for any serious venue. Authors who treat the first submission as one step in a documented, improving process publish better cerebellar science than authors who circulate an unchanged manuscript from journal to journal.
Frequently Asked Questions
What is the ISSN of The Cerebellum? The print ISSN is 1473-4222 and the electronic ISSN is 1473-4230. Either number identifies the same journal; the difference is the medium of publication.
Who publishes The Cerebellum? Springer, as Springer Science+Business Media, publishes the journal. The Springer journal code is 12311, and the official aims and scope, editorial board and submission information are maintained on the Springer Nature Link page for the journal.
When did The Cerebellum start publishing? Bibliographic listings record the start of publication in 2002. Its coverage in Scopus-based listings runs from 2002 forward, giving it more than two decades of continuous specialist publication.
Who founded and edits The Cerebellum? Mario Manto, a Belgian neurologist and professor of neuroanatomy, is recorded in biographical sources as the founding editor and editor-in-chief of the journal. Authors should confirm the current editor-in-chief and board on the Springer page at the time of submission, because board composition changes over a journal's life.
Is The Cerebellum the same journal as Cerebellum? Yes, in bibliographic practice the short title Cerebellum and the full title The Cerebellum refer to the same Springer journal with ISSNs 1473-4222 and 1473-4230. On JournalsWorld, two records exist for this single journal, under the titles The Cerebellum and Cerebellum; readers should treat their bibliographic facts as describing one publication.
What topics fit The Cerebellum best? Cerebellar ataxias and their genetics, cerebellar circuits and motor control, cerebellar contributions to cognition and emotion, development and imaging of the cerebellum, and treatment or rehabilitation of cerebellar disorders fit best, provided the cerebellum is central to the question.
How should I judge the journal's standing? Use dated, sourced metrics — a CiteScore of 5.9 and an h-index around 90 in Researcher.Life's Scopus-based listing, and an Impact Factor of 2.4 reported in June 2025 listings — together with the journal's indexing, longevity and relevance to your topic. No single number describes a specialist journal fairly.
Verdict for Authors and Readers
The Cerebellum occupies a clear and durable niche: it is the dedicated international journal for the science of one of the most neuron-rich and clinically consequential structures in the brain. Its value does not depend on competing with general neuroscience or general medicine titles. It depends on concentration — of expert editors, expert reviewers and readers who care specifically about cerebellar mechanisms, disorders and care. For a reader, it is an efficient way to follow a fast-moving field from one source, exactly as its publisher intended. For an author with genuinely cerebellar work, it offers a review process and an audience that understand the work's context without needing it explained from first principles.
The cautions are the normal ones for a selective specialist title. Scope fit is strict, review is expert and unforgiving of inflated claims, and metrics must be quoted from their proper sources rather than repeated from summaries. An author who respects those conditions, prepares a precise and transparent manuscript, and can state in one sentence what the paper adds to cerebellar science, will find this journal a serious and appropriate home. An author whose cerebellar content is incidental should choose elsewhere first, and save everyone, including themselves, a predictable decision.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
2 Years into the Pandemic: What Did We Learn About the COVID-19 and Cerebellum?
Aasef G. Shaikh, Mario Manto, Hiroshi Mitoma
2022-02 · DOI: 10.1007/s12311-021-01351-7Correction to: Genetic and Clinical Predictors of Ataxia in Pediatric Primary Mitochondrial Disorders
Juan Sebastian Martin‑Saavedra, Sara Reis Teixeira, Cesar Augusto Pinheiro Ferreira Alves, Fabrício Guimarães Gonçalves et al.
2022-02 · DOI: 10.1007/s12311-022-01370-yThe First 50 Years of Postnatal Neurogenesis in the Cerebellum: a Long Journey Across Phenomena, Mechanisms, and Human Disease
G. Giacomo Consalez
2022-02 · DOI: 10.1007/s12311-021-01315-xPostnatal Neurogenesis Beyond Rodents: the Groundbreaking Research of Joseph Altman and Gopal Das
Lazaros C. Triarhou, Mario Manto
2022-02 · DOI: 10.1007/s12311-021-01314-yCorrection to: Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome
Diana A. Abbasi, Thu T. A. Nguyen, Deborah A. Hall, Erin Robertson-Dick et al.
2022-02 · DOI: 10.1007/s12311-021-01321-zCommentary on “Subcellular Fractions of Adult and Developing Rat Cerebellum, by M. del Cerro, R. S. Snider and M. L. Oster, July 1969”
Manuel del Cerro
2021-08 · DOI: 10.1007/s12311-021-01287-yExploring Subcellular Cerebellar Fractions with the Electron Microscope
Lazaros C. Triarhou, Mario Manto
2021-08 · DOI: 10.1007/s12311-021-01286-zCorrection to: Abnormal Cerebellar Volume in Patients with Remitted Major Depression with Persistent Cognitive Deficits
Malte S. Depping, Mike M. Schmitgen, Claudia Bach, Lena Listunova et al.
2021-08 · DOI: 10.1007/s12311-021-01294-zSpinocerebellar Ataxia Type 1: One-Year Longitudinal Study to Identify Clinical and MRI Measures of Disease Progression in Patients and Presymptomatic Carriers
Anna Nigri, Lidia Sarro, Alessia Mongelli, Anna Castaldo et al.
2022-02 · DOI: 10.1007/s12311-021-01285-0Correction to: Neurofilament Light Chain is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
H. Donath, S. Woelke, R. Schubert, M. Kieslich et al.
2022-02 · DOI: 10.1007/s12311-021-01280-5Genetic and Clinical Predictors of Ataxia in Pediatric Primary Mitochondrial Disorders
Juan Sebastian Martin-Saavedra, Sara Reis Teixeira, Cesar Augusto Pinheiro Ferreira Alves, Fabrício Guimarães Gonçalves et al.
2022-02 · DOI: 10.1007/s12311-021-01276-1Delineating the Decussating Dentato-rubro-thalamic Tract and Its Connections in Humans Using Diffusion Spectrum Imaging Techniques
Si-Qi Ou, Peng-Hu Wei, Xiao-Tong Fan, Yi-He Wang et al.
2022-02 · DOI: 10.1007/s12311-021-01283-2Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome
Diana A. Abbasi, Thu T. A. Nguyen, Deborah A. Hall, Erin Robertson-Dick et al.
2022-02 · DOI: 10.1007/s12311-021-01262-7Cerebro-Cerebellar Response to Sequence Violation in a Cognitive Task: an fMRI Study
Yi-Shin Sheu, John E. Desmond
2022-02 · DOI: 10.1007/s12311-021-01279-yInteractions Between Cerebellum and the Intracortical Excitatory Circuits of Motor Cortex: a Mini-Review
George M. Opie, Wei-Yeh Liao, John G. Semmler
2022-02 · DOI: 10.1007/s12311-021-01278-zGaze-holding and anti-GAD antibody: prototypic heterogeneous motor dysfunction in immune disease
Wanchat Theeranaew, Fajun Wang, Fatema F. Ghasia, George Wilmot et al.
2022-02 · DOI: 10.1007/s12311-021-01272-5The Effects of Exergame on Postural Control in Individuals with Ataxia: a Rater-Blinded, Randomized Controlled, Cross-over Study
Ender Ayvat, Özge Onursal Kılınç, Fatma Ayvat, Cevher Savcun Demirci et al.
2022-02 · DOI: 10.1007/s12311-021-01277-0Diagnostic Yield of Whole Exome Sequencing for Adults with Ataxia: a Brazilian Perspective
Felipe Franco da Graça, Thiago M. Peluzzo, Luciana Cardoso Bonadia, Alberto Rolim Muro Martinez et al.
2022-02 · DOI: 10.1007/s12311-021-01268-1Correction to: From Cerebellar Apoplexy in 1849 to Cerebellar Stroke in the 2020s: Robert Dunn’s Contribution
Mario Manto, Lazaros C. Triarhou
2021-08 · DOI: 10.1007/s12311-021-01274-3Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
H. Donath, S. Woelke, R. Schubert, M. Kieslich et al.
2022-02 · DOI: 10.1007/s12311-021-01257-4Reviews
Community Reviews
Version History
October 17, 2026 at 12:21 pm
October 9, 2026